Fenbendazole Market – RegionalAnalysis
On the basis of region, theglobal FenbendazoleMarket is segmented into North America, Latin America, Europe, AsiaPacific, Middle East, and Africa.
Fenbendazole is a broad spectrumanthelmintic drug of class benzimidazole. Fenbendazole is used to removecertain gastrointestinal parasites from the stomach and intestines of animals.It is effective against roundworms, hookworms, whipworms, certain tapeworms,and parasites called strongyles and strongyloides, respectively. Fenbendazoleacts as an effective de-wormer as it controls & destroys these worms bypreventing their growth and reproduction.
Fenbendazole Market Driver
Increasing research anddevelopment activities for enhancing the efficiency of fenbendazole in treatingvarious diseases in animals and humans is a major factor boosting growth of thefenbendazole market. For instance, in August 2018, researchers from NationalCentre for Human Genome Studies and Research (NCHGSR), India, reported thatfenbendazole has potential to act as an effective anti-cancer agent.Fenbendazole can also be effective remedy in evading drug resistance commonlyencountered in cancer therapy. To study this, researchers first treated humannon-small cell lung cancer cells with fenbendazole and found tumor cell death.
* The sample copy includes: Report Summary, Table of Contents,Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2244
Since, developing a promisingmolecule into an approved drug often consume considerable time and cost,repurposing of veterinary drugs in treating diseases in humans can be effectiveand have shown promising results and is expected to show cost reduction withoutneed to develop new drugs.
Furthermore, approval of newfenbendazole drugs is expected to drive growth of the fenbendazole market. Forinstance, in January 2018, Merck Animal Health received approval from U.S. Foodand Drug Administration (USFDA), for its Safe-Guard AquaSol, a fenbendazoleoral suspension used in the treatment and control of adult Ascaridia galli inbroiler chickens and Heterakis gallinarum in breeding chickens via drinkingwater. Safe-Guard AquaSol is produced with an innovative wet-millingtechnology, which produces a highly stable suspension that can be convenientlyadministered to hens through drinking water.
Fenbendazole Market Restraint
Fenbendazole drug resistance dueimproper or excessive usage of drugs in horses is likely to affect the growthof fenbendazole market. For instance, according to National Equine HealthSurvey (NEHS) 2016, increasing use of fenbendazole drugs in horses in the U.S.has caused widespread resistance for the drug in these animals. According tothe same source, use of fenbendazole drugs in horses for treatment of encystedsmall red worm causes gut infection in the animals.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/fenbendazole-market-2244
North America is expected to holddominant position in the global fenbendazole market, owing to new developmentsin pet care and animal health. For instance, in June 2018, Cargill AnimalNutrition, a U.S.-based firm launched NutreBeef Safe-Guard (fenbendazole)Dewormer Mineral (Medicated) in one easy-to-use package. NutreBeef Safe-GuardDewormer Mineral combines Safe-Guard from Merck Animal Health, with a highquality, free-choice mineral formula from Cargill Animal Nutrition. Safe-Guardgoes directly into the gastrointestinal tract of the parasite and once ingestedby the parasite, it cannot be excreted thus, accumulation of Safe-Guard in theparasite eventually leads to parasite death.
Furthermore, Asia Pacific isexpected to witness significant growth in global fenbendazole market due toexpansions of production sites for fenbendazole by key players. For instance,in November 2017, Lasa Supergenerics Limited, a key player in manufacturing ofVeterinary APIs in India, launched trial production of fenbendazoleintermediates along with other drugs at its manufacturing unit IV to increasethe production of fenbendazole in India.
Key players operating in theglobal fenbendazole market include, Shaanxi Hanjiang Pharmaceutical Group Co.,Ltd., Hubei KangBaoTai Fine Chemical Co., Ltd, Merck Sharp & Dohme Corp.,Henan Purui Pharmaceutical Co., Ltd., Leo Bio-care Private Limited, SupharmaChem., Intervet Inc., LASA Supergenerics Limited, and Jiangsu Quality HorizonsPharmtech Co., Ltd.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2244
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
